Company / Inventory
Neurocrine Biosciences Inventory History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$69.0M
FY2025
5-year range
$30.5M / $69.0M
FY2021-FY2025
Trend
+20.2%
vs FY2024
Sector context
#52 of 108
Health Care
What the data says
At $69M, Neurocrine Biosciences's inventory ranks #52 of 108 in the Health Care sector. Inventory has increased for 8 consecutive years, from $1M in FY2017 to $69M in FY2025.
Based on SEC 10-K filings.
$69M in FY2025 with a 5-year CAGR of +19.8%.
Improved from $38M to $69M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +25.3%
- 5-Year CAGR
- +19.8%
- 10-Year CAGR
- -
Sector benchmark
#52 of 108 in Health CareTop 48% of 108This company $69.0M Sector average $862.4M
▼
-92.0% below sector average
Key checks
Key Insights
- Neurocrine Biosciences's inventory has grown for 8 consecutive years.
- 5-year CAGR of +19.8%, indicating consistent growth.
- In FY2025, inventory increased 20.2% year-over-year.
- Ranks #52 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $69.0M | +20.2% |
| FY2024 | $57.4M | +49.9% |
| FY2023 | $38.3M | +9.1% |
| FY2022 | $35.1M | +15.1% |
| FY2021 | $30.5M | +8.9% |
| FY2020 | $28.0M | +61.8% |
| FY2019 | $17.3M | +59.2% |
| FY2018 | $10.9M | +960.9% |
| FY2017 | $1.0M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026